GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Zymergen Inc (NAS:ZY) » Definitions » Cash Ratio

Zymergen (Zymergen) Cash Ratio : 4.09 (As of Jun. 2022)


View and export this data going back to 2021. Start your Free Trial

What is Zymergen Cash Ratio?

The Cash Ratio measures a company’s ability to meet its short-term obligations with cash and near-cash resources. It is calculated as a company's Cash, Cash Equivalents, Marketable Securities divides by its Total Current Liabilities. Zymergen's Cash Ratio for the quarter that ended in Jun. 2022 was 4.09.

Zymergen has a Cash Ratio of 4.09. It generally indicates that the company is able to cover all short-term debt and still have cash remaining.

The historical rank and industry rank for Zymergen's Cash Ratio or its related term are showing as below:

ZY' s Cash Ratio Range Over the Past 10 Years
Min: 1.3   Med: 3.95   Max: 11.16
Current: 4.09

During the past 3 years, Zymergen's highest Cash Ratio was 11.16. The lowest was 1.30. And the median was 3.95.

ZY's Cash Ratio is not ranked
in the Chemicals industry.
Industry Median: 0.53 vs ZY: 4.09

Zymergen Cash Ratio Historical Data

The historical data trend for Zymergen's Cash Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zymergen Cash Ratio Chart

Zymergen Annual Data
Trend Dec19 Dec20 Dec21
Cash Ratio
1.30 1.73 5.25

Zymergen Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22
Cash Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 11.16 4.11 5.25 3.81 4.09

Competitive Comparison of Zymergen's Cash Ratio

For the Specialty Chemicals subindustry, Zymergen's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zymergen's Cash Ratio Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Zymergen's Cash Ratio distribution charts can be found below:

* The bar in red indicates where Zymergen's Cash Ratio falls into.



Zymergen Cash Ratio Calculation

The Cash Ratio measures a company's ability to meet its short-term obligations with its cash and near-cash resources.

Zymergen's Cash Ratio for the fiscal year that ended in Dec. 2021 is calculated as:

Cash Ratio (A: Dec. 2021 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=386.105/73.553
=5.25

Zymergen's Cash Ratio for the quarter that ended in Jun. 2022 is calculated as:

Cash Ratio (Q: Jun. 2022 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=213.558/52.196
=4.09

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zymergen  (NAS:ZY) Cash Ratio Explanation

The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.

The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.

In general, the higher the cash ratio, the better the company's liquidity position.


Zymergen Cash Ratio Related Terms

Thank you for viewing the detailed overview of Zymergen's Cash Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Zymergen (Zymergen) Business Description

Traded in Other Exchanges
N/A
Address
5980 Horton Street, Suite 105, Emeryville, CA, USA, 94608
Zymergen Inc is a biofacturing company. Zymergen partners with nature to design, develop and manufacture bio-based breakthrough products that deliver value to customers in a broad range of industries. A unique combination of biology, chemistry, software and automation enables the company to design and create new materials.
Executives
Enakshi Singh officer: Chief Financial Officer 5980 HORTON ST., STE 105 EMERYVILLE CA 94608
Mina Kim officer: Chief Legal Officer C/O ACELYRIN, INC., 4149 LIBERTY CANYON RD., AGOURA HILLS CA 91301
Zachariah Serber director, officer: Chief Science Officer 5980 HORTON ST., STE 105 EMERYVILLE CA 94608
Aaron Kimball officer: Chief Technology Officer 5980 HORTON ST., STE 105 EMERYVILLE CA 94025
Jay T Flatley director 9885 TOWNE CENTRE DR, SAN DIEGO CA 92121
Svf Excaliber (cayman) Ltd 10 percent owner 27 HOSPITAL ROAD, WALKERS CORPORATE LTD., CAYMAN CORPORATE CENTRE, GEORGE TOWN, GRAND CAYMAN E9 KY-9008
Josh Hoffman director, officer: Chief Executive Officer 5980 HORTON ST., STE 105 EMERYVILLE CA 94608
Erik Jedidiah Dean officer: VP Operations and Engineering 5980 HORTON ST., STE 105 EMERYVILLE CA 94608
Rohit Sharma director 575 HIGH STREET PALO ALTO CA 94301
Travis Murdoch director 1 CIRCLE STAR WAY SAN CARLOS CA 94070
Matthew Ocko director 270 UNIVERSITY AVENUE, PALO ALTO CA 94301
Svf Endurance (cayman) Ltd 10 percent owner C/O WALKERS CORPORATE LIMITED, 27 HOSPITAL ROAD, GEORGE TOWN E9 KY1-9008
Softbank Vision Fund (aiv M1) L.p. 10 percent owner 251 LITTLE FALLS DRIVE, WILMINGTON DE 19808
Sb Investment Advisers (uk) Ltd 10 percent owner 69 GROSVENOR STREET, LONDON X0 W1K 3JP
Christine Marie Gorjanc director 4500 GREAT AMERICA PARKWAY, SANTA CLARA CA 95054